These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 20702856)

  • 1. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity.
    Saccheri F; Pozzi C; Avogadri F; Barozzi S; Faretta M; Fusi P; Rescigno M
    Sci Transl Med; 2010 Aug; 2(44):44ra57. PubMed ID: 20702856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells.
    Mendoza-Naranjo A; Saéz PJ; Johansson CC; Ramírez M; Mandakovic D; Pereda C; López MN; Kiessling R; Sáez JC; Salazar-Onfray F
    J Immunol; 2007 Jun; 178(11):6949-57. PubMed ID: 17513744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells.
    Cioca DP; Deak E; Cioca F; Paunescu V
    J Immunother; 2006; 29(1):41-52. PubMed ID: 16365599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupled for cross-presentation in tumor immunotherapy.
    Pang B; Neefjes J
    Sci Transl Med; 2010 Aug; 2(44):44ps40. PubMed ID: 20702855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
    Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
    Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
    Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
    Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
    von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
    J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
    Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capacities of migrating CD1b+ lymph dendritic cells to present Salmonella antigens to naive T cells.
    Olivier M; Foret B; Le Vern Y; Guilloteau LA
    PLoS One; 2012; 7(1):e30430. PubMed ID: 22279590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.
    Schnurr M; Chen Q; Shin A; Chen W; Toy T; Jenderek C; Green S; Miloradovic L; Drane D; Davis ID; Villadangos J; Shortman K; Maraskovsky E; Cebon J
    Blood; 2005 Mar; 105(6):2465-72. PubMed ID: 15546948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gap junctions in melanoma and their impact on Melan-A/MART-1-specific CD8⁺ T lymphocyte emergence.
    Benlalam H; Carré T; Jalil A; Noman Z; Caillou B; Vielh P; Tittarelli A; Robert C; Chouaib S
    J Mol Med (Berl); 2013 Oct; 91(10):1207-20. PubMed ID: 23744108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells.
    Bossi G; Buisson S; Oates J; Jakobsen BK; Hassan NJ
    Cancer Immunol Immunother; 2014 May; 63(5):437-48. PubMed ID: 24531387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.
    Lund AW; Duraes FV; Hirosue S; Raghavan VR; Nembrini C; Thomas SN; Issa A; Hugues S; Swartz MA
    Cell Rep; 2012 Mar; 1(3):191-9. PubMed ID: 22832193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity.
    Abdel-Wahab Z; DeMatos P; Hester D; Dong XD; Seigler HF
    Cell Immunol; 1998 May; 186(1):63-74. PubMed ID: 9637766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.
    Fessenden TB; Stopfer LE; Chatterjee F; Zulueta J; Mesfin J; Cordero Dumit T; Reijers I; Hoefsmit EP; Blank C; White F; Spranger S
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35820727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dioscin potentiates the antitumor effect of suicide gene therapy in melanoma by gap junction intercellular communication-mediated antigen cross-presentation.
    Zhang W; Lin L; Zhang Y; Zhao T; Zhan Y; Wang H; Fang J; Du B
    Biomed Pharmacother; 2022 Jun; 150():112973. PubMed ID: 35468581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cx43-Gap Junctions Accumulate at the Cytotoxic Immunological Synapse Enabling Cytotoxic T Lymphocyte Melanoma Cell Killing.
    Hofmann F; Navarrete M; Álvarez J; Guerrero I; Gleisner MA; Tittarelli A; Salazar-Onfray F
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model.
    Matheoud D; Baey C; Vimeux L; Tempez A; Valente M; Louche P; Le Bon A; Hosmalin A; Feuillet V
    PLoS One; 2011 Apr; 6(4):e19104. PubMed ID: 21552572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.